Form 4: NeuroPace Director Lisa Andrade Receives Equity Compensation Through Stock Option Grant

NeuroPace Inc. Director Lisa Andrade was granted 8,745 stock options with an exercise price of $13.15, as disclosed in a recent SEC Form 4 filing.

Summary

• Lisa Andrade, a Director at NeuroPace Inc. (NPCE), was granted 8,745 stock options.
• The transaction date for this grant was June 6, 2025.
• The exercise price for these stock options is $13.15 per share.
• The options will vest in twelve (12) equal consecutive monthly installments, contingent upon Ms. Andrade's continuous service through each vesting date.
• The expiration date for these stock options is June 5, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a Form 4 is a factual disclosure, the grant of options to a director is a standard practice that aligns management interests with shareholders, which is generally viewed favorably.

Positives

• The grant of stock options aligns the interests of Director Lisa Andrade with those of the shareholders, as the value of her compensation is tied to the company's stock performance.
• Equity compensation is a standard practice for attracting and retaining qualified board members.

Future Outlook

This Form 4 filing is a disclosure of a past transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

The granting of stock options to directors is a common form of non-cash compensation in the medical device and biotechnology industries, used to incentivize long-term commitment and align leadership interests with shareholder value creation.

Comparison to Industry Standards

• The practice of granting stock options to directors is a standard component of compensation packages across publicly traded companies, particularly within the technology and healthcare sectors, aiming to align director incentives with company performance.
• The vesting schedule of 12 equal consecutive monthly installments is a common approach to ensure continuous service and long-term commitment from board members, comparable to practices seen at companies like Medtronic or Boston Scientific for their non-executive directors.

Related Party Transactions

• The grant of stock options to Lisa Andrade, a Director of NeuroPace Inc., constitutes a related party transaction, which is a standard form of compensation for board members.

Stakeholder Impact

• Shareholders: The grant of stock options aims to align the director's financial interests with the long-term performance of the company, potentially benefiting shareholders if the stock price increases.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The stock options will vest in twelve (12) equal consecutive monthly installments, subject to Lisa Andrade's continuous service.

Key Dates

Recommendation

Keywords

NeuroPace, NPCE, Stock Option, Director Compensation, Equity Grant, Form 4, Insider Transaction, Vesting